Use of 4-(2-fluorophenyl)-6-methyl-2-(1-pipera zinyl)thieno[2,3-D]pyrimidine for the treatment of pain

Details for Australian Patent Application No. 2005200045 (hide)

International Classifications

Event Publications

20 January 2005 Complete Application Filed

27 January 2005 Application Open to Public Inspection

Published as AU-A-2005200045

14 February 2008 Assignment before Grant

Arachnova Therapeutics The application has been assigned to Dynogen Pharmaceuticals, Inc. Assignments before Grant, Section 113

30 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.